BTCY
OQB Biotricity, Inc.$0.0573 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0573, and at the day’s high of $0.0598
- YTD change
- -80.90%
- vs 20-day SMA
- -31.49%
- vs 200-day SMA
- -71.64%
Price ranges
Price & Performance
-0.16 (-73.99%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 100.0% away from all-time highs of $117.0000
- BTCY is down 81% since the beginning of the year
- BTCY is down 90% over the past 12 months
- BTCY is down 45% over the past 1 month
- 1% of all BTCY investors are betting against BTCY
BTCY reads poor: price sits below both the 20- and 200-day averages, the 12-month move is -88.9%.
- Previous minute
- +$0.0000
- Last hour
- +$0.0070
- Last 5 days
- -17.74%
- vs 8-day SMA
- -16.37%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Biotricity, Inc. is a medical technology company, which engages in biometric data monitoring solutions. Its products include Bioflux, Biocore, Bioheart, Biokit, and Biocare. The company was founded by Waqaas Al-Siddiq and Peter McGoldrick on January 25, 2011 and is headquartered in Redwood City, CA.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.